Compare Divis Laboratories with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES CIPLA DIVIS LABORATORIES/
CIPLA
 
P/E (TTM) x 36.4 30.6 119.0% View Chart
P/BV x 10.1 4.3 234.9% View Chart
Dividend Yield % 0.6 0.5 110.2%  

Financials

 DIVIS LABORATORIES   CIPLA
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-21
CIPLA
Mar-21
DIVIS LABORATORIES/
CIPLA
5-Yr Chart
Click to enlarge
High Rs3,913879 445.4%   
Low Rs1,824411 444.3%   
Sales per share (Unadj.) Rs262.5237.6 110.5%  
Earnings per share (Unadj.) Rs74.729.8 251.0%  
Cash flow per share (Unadj.) Rs84.443.0 196.2%  
Dividends per share (Unadj.) Rs20.005.00 400.0%  
Avg Dividend yield %0.70.8 89.9%  
Book value per share (Unadj.) Rs350.1226.7 154.4%  
Shares outstanding (eoy) m265.47806.46 32.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x10.92.7 402.7%   
Avg P/E ratio x38.421.6 177.3%  
P/CF ratio (eoy) x34.015.0 226.9%  
Price / Book Value ratio x8.22.8 288.2%  
Dividend payout %26.816.8 159.3%   
Avg Mkt Cap Rs m761,517519,826 146.5%   
No. of employees `000NANA-   
Total wages/salary Rs m8,25832,518 25.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m69,694191,596 36.4%  
Other income Rs m6272,698 23.2%   
Total revenues Rs m70,321194,294 36.2%   
Gross profit Rs m28,61142,487 67.3%  
Depreciation Rs m2,55610,677 23.9%   
Interest Rs m211,607 1.3%   
Profit before tax Rs m26,66032,901 81.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,8188,888 76.7%   
Profit after tax Rs m19,84324,013 82.6%  
Gross profit margin %41.122.2 185.1%  
Effective tax rate %25.627.0 94.7%   
Net profit margin %28.512.5 227.2%  
BALANCE SHEET DATA
Current assets Rs m67,906132,095 51.4%   
Current liabilities Rs m17,28445,916 37.6%   
Net working cap to sales %72.645.0 161.5%  
Current ratio x3.92.9 136.6%  
Inventory Days Days1068 14.1%  
Debtors Days Days8787 13,375.9%  
Net fixed assets Rs m45,963116,277 39.5%   
Share capital Rs m5311,613 32.9%   
"Free" reserves Rs m92,415181,232 51.0%   
Net worth Rs m92,946182,844 50.8%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m113,869248,372 45.8%  
Interest coverage x1,270.521.5 5,916.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.8 79.3%   
Return on assets %17.410.3 169.1%  
Return on equity %21.313.1 162.6%  
Return on capital %28.717.7 162.1%  
Exports to sales %031.3 0.0%   
Imports to sales %18.810.9 172.6%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs m13,12720,911 62.8%   
Fx inflow Rs m58,87768,051 86.5%   
Fx outflow Rs m13,34120,911 63.8%   
Net fx Rs m45,53647,140 96.6%   
CASH FLOW
From Operations Rs m19,46937,552 51.8%  
From Investments Rs m751-23,872 -3.1%  
From Financial Activity Rs m-349-13,299 2.6%  
Net Cashflow Rs m19,872509 3,903.3%  

Share Holding

Indian Promoters % 51.9 13.5 385.0%  
Foreign collaborators % 0.0 20.1 -  
Indian inst/Mut Fund % 36.8 48.6 75.6%  
FIIs % 18.5 26.6 69.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 66.4 72.4%  
Shareholders   309,397 418,584 73.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    AUROBINDO PHARMA    



Today's Market

Sensex, Nifty End Lower as Realty & IT Stocks Witness Selling; Asian Paints, Berger Paints Slump 8%(Closing)

After opening on a positive note, Indian share markets failed to hold early gains and ended the day lower.

Related Views on News

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


May 25, 2022 03:30 PM

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES 8-QTR ANALYSIS

COMPARE DIVIS LABORATORIES WITH

MARKET STATS